BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29201944)

  • 1. Bystander effects of nitric oxide in anti-tumor photodynamic therapy.
    Bazak J; Fahey JM; Wawak K; Korytowski W; Girotti AW
    Cancer Cell Microenviron; 2017; 4(1):. PubMed ID: 29201944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced aggressiveness of bystander cells in an anti-tumor photodynamic therapy model: Role of nitric oxide produced by targeted cells.
    Bazak J; Fahey JM; Wawak K; Korytowski W; Girotti AW
    Free Radic Biol Med; 2017 Jan; 102():111-121. PubMed ID: 27884704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bystander Effects of Nitric Oxide in Cellular Models of Anti-Tumor Photodynamic Therapy.
    Bazak J; Korytowski W; Girotti AW
    Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31661869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyper-Aggressiveness of Bystander Cells in an Anti-Tumor Photodynamic Therapy Model: Role of Nitric Oxide Produced by Targeted Cells.
    Bazak J; Korytowski W; Girotti AW
    Crit Rev Oncog; 2023; 28(1):15-25. PubMed ID: 37824384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of nitric oxide in tumor cells as a negative adaptation to photodynamic therapy.
    Girotti AW
    Lasers Surg Med; 2018 Jul; 50(5):590-598. PubMed ID: 29504635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-Tumor Activity of Endogenous Nitric Oxide in Anti-Tumor Photodynamic Therapy: Recently Recognized Bystander Effects.
    Girotti AW; Bazak J; Korytowski W
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of pro-tumor nitric oxide by anti-tumor photodynamic therapy.
    Girotti AW; Fahey JM
    Biochem Pharmacol; 2020 Jun; 176():113750. PubMed ID: 31836386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic Therapy as an Oxidative Anti-Tumor Modality: Negative Effects of Nitric Oxide on Treatment Efficacy.
    Girotti AW; Fahey JM; Korbelik M
    Pharmaceutics; 2021 Apr; 13(5):. PubMed ID: 33919266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Negative Impact of Cancer Cell Nitric Oxide on Photodynamic Therapy.
    Fahey JM; Girotti AW
    Methods Mol Biol; 2022; 2451():21-31. PubMed ID: 35505007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of iNOS/NO in Cancer Cells That Survive a Photodynamic Challenge: Role of No in Accelerated Cell Migration and Invasion.
    Girotti AW; Korytowski W
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide-elicited resistance to anti-glioblastoma photodynamic therapy.
    Girotti AW; Fahey JM; Korytowski W
    Cancer Drug Resist; 2020 3rd Quarter; 3(3):401-414. PubMed ID: 33073206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric Oxide-Mediated Resistance to Antitumor Photodynamic Therapy.
    Girotti AW
    Photochem Photobiol; 2020 May; 96(3):500-505. PubMed ID: 31545517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nitric oxide in hyper-aggressiveness of tumor cells that survive various anti-cancer therapies.
    Girotti AW; Fahey JF; Korytowski W
    Crit Rev Oncol Hematol; 2022 Nov; 179():103805. PubMed ID: 36087851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Means by Which Nitric Oxide can Antagonize Photodynamic Therapy.
    Girotti AW; Fahey JM; Korytowski W
    Curr Med Chem; 2016; 23(24):2754-2769. PubMed ID: 27776475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the Anti-Tumor Efficacy of Photodynamic Therapy by Nitric Oxide.
    Girotti AW
    Cancers (Basel); 2016 Oct; 8(10):. PubMed ID: 27775600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upstream signaling events leading to elevated production of pro-survival nitric oxide in photodynamically-challenged glioblastoma cells.
    Fahey JM; Korytowski W; Girotti AW
    Free Radic Biol Med; 2019 Jun; 137():37-45. PubMed ID: 30991141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric Oxide Antagonism to Anti-Glioblastoma Photodynamic Therapy: Mitigation by Inhibitors of Nitric Oxide Generation.
    Fahey JM; Girotti AW
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30781428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated migration and invasion of prostate cancer cells after a photodynamic therapy-like challenge: Role of nitric oxide.
    Fahey JM; Girotti AW
    Nitric Oxide; 2015 Sep; 49():47-55. PubMed ID: 26068242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide-mediated resistance to photodynamic therapy in a human breast tumor xenograft model: Improved outcome with NOS2 inhibitors.
    Fahey JM; Girotti AW
    Nitric Oxide; 2017 Jan; 62():52-61. PubMed ID: 28007662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Endogenous Nitric Oxide in Hyperaggressiveness of Tumor Cells that Survive a Photodynamic Therapy Challenge.
    Girotti AW
    Crit Rev Oncog; 2016; 21(5-6):353-363. PubMed ID: 29431083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.